Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.
Publication
, Journal Article
Zhou, F; Liu, Y-M; Xie, J; Li, H; Lei, F; Yang, H; Qin, J-J; Cai, J; Zhang, X-J; Wu, B; Xia, M; Xiang, D; Yang, C; Ma, X; Xu, Q; Lu, Z ...
Published in: Hypertension
August 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Hypertension
DOI
EISSN
1524-4563
Publication Date
August 2020
Volume
76
Issue
2
Start / End Page
e15 / e17
Location
United States
Related Subject Headings
- SARS-CoV-2
- Renin-Angiotensin System
- Pneumonia, Viral
- Pandemics
- Humans
- Coronavirus Infections
- Cardiovascular System & Hematology
- COVID-19
- Betacoronavirus
- Angiotensins
Citation
APA
Chicago
ICMJE
MLA
NLM
Zhou, F., Liu, Y.-M., Xie, J., Li, H., Lei, F., Yang, H., … Xia, J. (2020). Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality. Hypertension, 76(2), e15–e17. https://doi.org/10.1161/HYPERTENSIONAHA.120.15622
Zhou, Feng, Ye-Mao Liu, Jing Xie, Haomiao Li, Fang Lei, Huilin Yang, Juan-Juan Qin, et al. “Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.” Hypertension 76, no. 2 (August 2020): e15–17. https://doi.org/10.1161/HYPERTENSIONAHA.120.15622.
Zhou F, Liu Y-M, Xie J, Li H, Lei F, Yang H, et al. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality. Hypertension. 2020 Aug;76(2):e15–7.
Zhou, Feng, et al. “Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.” Hypertension, vol. 76, no. 2, Aug. 2020, pp. e15–17. Pubmed, doi:10.1161/HYPERTENSIONAHA.120.15622.
Zhou F, Liu Y-M, Xie J, Li H, Lei F, Yang H, Qin J-J, Cai J, Zhang X-J, Wu B, Xia M, Xiang D, Yang C, Ma X, Xu Q, Lu Z, Lu H, Xia X, Wang D, Liao X, Peng G, Yang J, Huang X, Zhang B-H, Yuan Y, Wei X, Liu PP, Wang Y, Zhang P, She Z-G, Xia J. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality. Hypertension. 2020 Aug;76(2):e15–e17.
Published In
Hypertension
DOI
EISSN
1524-4563
Publication Date
August 2020
Volume
76
Issue
2
Start / End Page
e15 / e17
Location
United States
Related Subject Headings
- SARS-CoV-2
- Renin-Angiotensin System
- Pneumonia, Viral
- Pandemics
- Humans
- Coronavirus Infections
- Cardiovascular System & Hematology
- COVID-19
- Betacoronavirus
- Angiotensins